Physician profile
Mark D Baganz
NPI 1982768966
$17,123.75
in general payments reported to CMS, 2019-2025
7 companies · $89.45 in 2025
The $89.45 reported for 2025 was less than what a typical Diagnostic Radiology provider received nationally (typical 2025 total: $112).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,713 · 2020: $4,913 · 2021: $1,868 · 2022: $5,541 · 2025: $89.45.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $89.45.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $89.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hyperfine Research, INC. | $9,375.00 | 2019-2020 | |
| Hyperfine Operations, INC. | $6,725.00 | 2021-2022 | |
| Ge Healthcare | $358.86 | 2020-2022 | |
| Canon Medical Systems USA, INC. | $358.39 | 2019-2022 | |
| Progenics Pharmaceuticals, INC. | $116.91 | 2022 | |
| Horizon Therapeutics Plc | $100.14 | 2022 | |
| Blue Earth Diagnostics | $89.45 | 2025 | Posluma |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Baganz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.